141
Participants
Start Date
October 14, 2020
Primary Completion Date
October 28, 2022
Study Completion Date
December 16, 2022
Ferric citrate
Ferric citrate will be provided as a 1g tablet. All intervention doses will be based on hemoglobin levels.
Placebo
Matching placebo will be provided as a 1g tablet. All intervention doses will be based on hemoglobin levels.
Department of Integrated Diagnostics and Therapeutics, National Taiwan University Hospital, Taipei
Division of Nephrology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei
Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung
Division of Nephrology, Department of Internal Medicine, Far East Memorial Hospital, New Taipei City
Division of Nephrology, Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, Taipei County
Division of Nephrology, Department of Internal Medicine, China Medical University Hospital, Taichung
Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang-Gung Memorial Hospital, Kaohsiung City
National Cheng Kung University Hospital, Tainan City
Taipei Medical University Hospital, Taipei
Taipei Municipal Wanfang Hospital, Taipei
Chang Gung Memorial Hospital, Linkou, Taoyuan District
Lead Sponsor
Panion & BF Biotech Inc.
INDUSTRY